Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case–control studyResearch in context

Summary: Background: After primary vaccination schemes with rAd26-rAd5 (Sputnik V), ChAdOx1 nCoV-19, BBIBP-CorV or heterologous combinations, the effectiveness of homologous or heterologous boosters (Sputnik V, ChAdOx, Pfizer-BioNTech, Moderna) against SARS-CoV-2 infections, hospitalisations and de...

Full description

Bibliographic Details
Main Authors: Soledad González, Santiago Olszevicki, Alejandra Gaiano, Martín Salazar, Lorena Regairaz, Ana Nina Varela Baino, Erika Bartel, Teresa Varela, Veronica V. González Martínez, Santiago Pesci, Lupe Marín, Juan Ignacio Irassar, Leticia Ceriani, Enio Garcia, Nicolás Kreplak, Elisa Estenssoro, Franco Marsico
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:The Lancet Regional Health. Americas
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X23001813

Similar Items